13 APRIL NEW ZEALAND GAZETTE 857

Any interested party that might request the Secretary of Commerce to initiate a review before the termination date referred to above, should be aware that positive evidence justifying the need for a review must be provided to the Secretary.

If an application is received which provides positive evidence justifying the need for a review, the Secretary must undertake a review investigation and report to the Minister of Commerce within 180 days on whether the anti-dumping duties should continue to be applied. Positive evidence justifying the need for a review would need to provide reasons for believing that the expiration of anti-dumping duties would see the continuation or recurrence of dumping of abrasive discs and wheels from Korea and Taiwan, and for believing that such dumping would be likely to cause the continuation or recurrence of material injury to the New Zealand industry producing abrasive discs and wheels. The reasons should be supported by evidence and not based on mere allegations or assertions.

Further information is available from the Manager, Trade Remedies Group, Competition and Enterprise Branch, Ministry of Economic Development, P.O. Box 1473, Wellington, or on facsimile (04) 499 8508 or email traderem@med.govt.nz

Signed at Wellington this 11th day of April 2000.

RORY McLEOD, Manager, Trade Remedies Group.

Refer to “Final Determination: Abrasive Discs and Wheels From Korea and Taiwan” published in the New Zealand Gazette of 18 April 1996 at pages 1049-1050.

go2695

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Combantrin-1 with Mebendazole Chocolate Squares

Active Ingredient(s): Mebendazole 100mg

Dosage Form: Medicated chocolate

New Zealand Sponsor: Pfizer Laboratories Limited

Manufacturer(s): Mentholatum Australasia Pty Limited, Scoresby, Victoria, Australia

Product: Levobunolol Hydrochloride Eye Drops 0.5%

Active Ingredient(s): Levobunolol hydrochloride 0.5%w/v

Dosage Form: Eye drops, solution

New Zealand Sponsor: Pacific Pharmaceuticals Limited

Manufacturer(s): Alcon Couvreur SA, Puurs, Belgium

Product: Rebetol

Active Ingredient(s): Ribavirin 200mg

Dosage Form: Capsule

New Zealand Sponsor: Schering-Plough Pty Limited

Manufacturer(s): Schering-Plough Products Inc, Las Piedras, Puerto Rico

Note: For use in combination only.

Product: Rebetron (Combination Product)

Active Ingredient(s): Interferon alfa-2b 15MIU/mL

Dosage Form: Solution for injection

Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico

Active Ingredient(s): Ribavirin 200mg

Dosage Form: Capsule

New Zealand Sponsor: Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Manufacturer(s): Schering-Plough Products Inc, Las Piedras, Puerto Rico

Product: Rebetron (Combination Product)

Active Ingredient(s): Interferon alfa-2b 6MIU/mL

Dosage Form: Solution for injection

Manufacturer(s): Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Schering-Plough Products Inc, Las Piedras, Puerto Rico

Active Ingredient(s): Ribavirin 200mg

Dosage Form: Capsule